Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine

References

• Dawood M. Y. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet. Gynecol. Scand. Suppl. 1986; 138: 7
   Google Scholar
• Pickles V. R., Hall W. J., Best F. A., Smith G. N. Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrheic subjects. J. Obstet. Gynaecol. Br. Com. 1965; 72: 185
   PubMedGoogle Scholar
• Ylikorkala O., Dawood M. Y. New concepts in dysmenorrhea. Am. J. Obstet. Gynecol. 1978; 130: 833
   PubMed Web of Science ®Google Scholar
• Dawood M. Y. Hormones, prostaglandins and dysmenorrhea. Dysmenorrhea, M. Y. Dawood. Williams and Wilkins, Baltimore and London 1981; 21
   Google Scholar
• Downie J., Poyser N. L., Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. J. Physiol. 1974; 236: 465
   PubMed Web of Science ®Google Scholar
• Singh E. J., Baccarini I. M., Zuspan F. P. Levels of prostaglandins F2a and E2 in human endometrium during menstrual cycle. Am. J. Obstet. Gynecol 1975; 121: 1003
   PubMed Web of Science ®Google Scholar
• Willman E. A., Collins W. P., Clayton S. G. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br. J. Obstet. Gynaecol. 1976; 83: 337
   PubMedGoogle Scholar
• Rees M. C. P., Anderson A. B. M., Demers L. M., Turnbull A. Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss. J. Clin. Endocrinol. Metab. 1984; 58: 813
   Google Scholar
• Lundstrom V., Greene K. Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. Am. J. Obstet. Gynecol. 1978; 130: 640
   PubMed Web of Science ®Google Scholar
• Lumsden M. A., Kelly R. W., Baird D. T. Primary dysmenorrhea: the importance of both prostaglandin E2 and F2α. Br. J. Obstet. Gynaecol. 1983; 90: 1135
   PubMedGoogle Scholar
• Powell A. M., Chan W. Y., Alvin P., Litt I. F. Menstrual PGF2α, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea. Prostaglandins 1985; 29: 273
   PubMed Web of Science ®Google Scholar
• Dawood M. Y. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am. J. Med. 1988; 84(Suppl. 5A)23
   Google Scholar
• Strömberg P., Åkerlund M., Forsling M. L., Granström E., Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet. Gynecol. Scand. 1984; 63: 533
   PubMed Web of Science ®Google Scholar
• Dawood M. Y. Dysmenorrhea and prostaglandins: pharmacological and therapeutic considerations. Drugs 1981; 122: 42
   Google Scholar
• Owen P. R. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Am. J. Obstet. Gynecol. 1984; 148: 96
   PubMed Web of Science ®Google Scholar
• Guttadauria M. The clinical pharmacology of piroxicam. Acta Obstet. Gynecol. Scand. Suppl. 1986; 138: 11
   Google Scholar
• Kauppila A., Mäkilä U. M., Mäkäräinen L., Puolakka J., Seppälä A. Tiaprofenic acid in the treatment of primary dysmenorrhea. Eur. J. Obstet. Gynecol. Reprod. Biol 1986; 22: 359
   PubMed Web of Science ®Google Scholar
• Milsom I., Andersch B. Effect ofibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhea. Br. J. Obstet. Gynaecol. 1984; 91: 1129
   PubMedGoogle Scholar
• Dawood M. Y. Ibuprofen and dysmenorrhea. Am. J. Med. 1984; 77: 87
   PubMed Web of Science ®Google Scholar
• Chan W. Y., Dawood M. Y., Fuchs F. Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. Am. J. Med. 1981; 70: 535
   PubMed Web of Science ®Google Scholar
• Chan W. Y. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea. Ann. Rev. Pharmacol. Toxicol. 1983; 23: 131
   PubMed Web of Science ®Google Scholar
• Pulkkinen M. O. Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated withnimesulide. J. Clin. Pharmacol. 1987; 27: 65
   PubMed Web of Science ®Google Scholar
• Massobrio M., Benedetto C., Rosi A., Marozio L., Nigam S. Eicosanoids and platelet activating factor in dysmenorrhea. Pain and Reproduction, A. R. Genazzani, G. Nappi, F. Facchinetti, E. Martignoni. Parthenon Publishing, Carnforth 1988; 63
   Google Scholar
• Weichman B. M., Tucker S. S. Contraction of guinea pig uterus by synthetic leukotrienes. Prostaglandins 1982; 24: 245
   Google Scholar
• Carraher R., Hahn D. W., Ritchie D. M., McGuire J. L. Involvement of lipoxygenase products in myometrial contractions. Prostaglandins 1983; 26: 23
   PubMedGoogle Scholar
• Lundstrom V. The uterus. Prostaglandins and Their Inhibitors in Clinical Obstetrics and Gynaecologylstedn, M. Bygdeman, G. S. Berger, L. G. Keith. MTP Press, Lancaster 1986; 59
   Google Scholar
• Rees M. C. P., Di Marzo V., Tippins J. R., Morris H. R., Turnbull A. C. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. J. Endocrinol 1987; 113: 291
   PubMed Web of Science ®Google Scholar
• Rees M. C. P., Parry D. M., Anderson A. B. M., Turnbull A. C. Immunohistochemical localization of cyclo-oxygenase in the human uterus. Prostaglandins 1982; 23: 207
   Google Scholar
• Lumsden M. A., Brown A., Baird D. T. Prostaglandin production from homogenates of separated glandular epithelium and stroma from human endometrium. Prostaglandins 1984; 28: 485
   Google Scholar
• Robertson W. B. Normal endometrium. The Endometrium1st edn. Butterworths, London 1981; 7
   Google Scholar
• Chegini N., Rao Ch. V. The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue. J. Clin. Endocrinol. Metab. 1988; 58: 813
   Google Scholar
• Camussi G., Brentjens J., Bussolino F., Tetta C. Role of platelet activating factor in immunopathological reactions. Adv. Inflam. Res. 1986; 11: 97
   Google Scholar
• Camussi G., Montrucchio G., Antro C., Tetta C., Ragni R., Emanuelli G. In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue. Pan. Med. 1981; 23: 179
   Google Scholar
• Benveniste J., Tencé M., Varenne P., Bidault J., Boullet C., Polonsky I. Semi-synthése et structure proposée du facteur activant les plaquettes (P. A.F.): PAF-acether, un alkyl ether analog de la lyso-phosphatidylcholine. C. R. Acad. Sci. (Paris) 1979; 289: 1037
   Google Scholar
• Tetta C., Montrucchio G., Alloatti G., Roffinello C., Emanuelli G., Benedetto C., Camussi G., Massobrio M. Platelet activating factor contracts human myometrium in vitro. Proc. Soc. Exp. Biol. Med. 1986; 183: 376
   Google Scholar
• Montrucchio G., Massobrio M., Alloatti G., Roffinello C., Emanuelli G., Benedetto C., Piva S., Vigliani M. C., Camussi G., Tetta C. In vitro oxytocic activity of platelet-activating factor on human myometrium. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, B. Samuelsson, R. Paoletti, P. W. Ramwell. Raven Press, New York 1987; 17B: 1129
   Google Scholar
• Åkerlund M., Strömberg P., Forsling M. L. Primary dysmenorrhea and vasopressin. Br. J. Obstet. Gynaecol. 1979; 86: 484
   PubMedGoogle Scholar
• Strömberg P., Åkerlund M., Forsling M. L., Granstrom E., Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet. Gynecol. Scand. 1984; 63: 533
   PubMed Web of Science ®Google Scholar
• Hauksson A., Åkerlund M., Melin P. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist. Br. J. Obstet. Gynaecol. 1988; 95: 898
   PubMedGoogle Scholar
• Strömberg P., Åkerlund M., Forsling M. L., Kindahl H. Involvement of prostaglandins in vasopressin stimulation of the human uterus. Br. J. Obstet. Gynaecol. 1983; 90: 332
   PubMedGoogle Scholar
• Strömberg P., Forsling M. L., Åkerlund M. Effect of prostaglandin inhibition of vasopressin levels in women with primary dysmenorrhea. Obstet. Gynecol. 1981; 58: 206
   PubMed Web of Science ®Google Scholar
• Rees M. Dysmenorrhea. Br. J. Obstet. Gynaecol. 1988; 95: 833
   Google Scholar
• Demers L. M., Hahn D. W., McGuire J. L. Newer concepts in dysmenorrhea research. Premenstrual Syndrome and Dysmenorrhea, L. M. Demers, M. J. Dawood, J. L. McGuire. Urban & Schwarzenburg, Baltimore 1984; 205
   Google Scholar
• Lumsden A. Dysmenorrhea – Why prostaglandin synthetase inhibitors are effective. Prostaglan. Perspec 1985; 1: 6
   Google Scholar
• Serfaty D. A comparative crossover study of piroxicam vs mefena-mic acid and diclofenac in France. Acta Obstet. Gynecol. Scand. Suppl. 1986; 138: 19
   PubMedGoogle Scholar
• Vargyas J. M., Campeau J. D., Mischell D. R., Jr. Treatment of menorrhagia with meclofenamate sodium. Am. J. Obstet. Gynecol. 1987; 157: 944
   PubMedGoogle Scholar
• Pasquale S. A., Rathauser R., Mitzi Dolese H. A double-blind placebo study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea. Am. J. Med. 1988; 84(Suppl. 5A)30
   Google Scholar
• Benedetto C., Rosi A., Piccioni V., Marozio L., Massobrio M. Peripheral plasma levels of prostaglandins in dysmenorrheic women treated with flurbiprofen. Pain and Reproduction, A. R. Genazzani, G. Nappi, F. Facchi-netti, E. Martignoni. Parthenon Publishing, Carnforth 1988; 251
   Google Scholar
• Plantema F. Worldwide studies comparing piroxicam and naproxen. Acta Obstet. Gynecol. Scand. Suppl. 1986; 138: 15
   Google Scholar
• Kauppila A., Ronnberg L. Naproxen sodium in dysmenorrhea secondary to endometriosis. Obstet. Gynecol. 1985; 65: 379
   PubMed Web of Science ®Google Scholar
• Alvin P. E., Litt I. F. Special article – Current status of the etiology and management of dysmenorrhea in adolescence. Pediatrics 1982; 70: 516
   PubMed Web of Science ®Google Scholar
• Muse K. N., Wilson E. A. How does mild endometriosis cause infertility?. Fertil. Steril. 1982; 38: 145
   PubMed Web of Science ®Google Scholar
• Scommegna A. Secondary dysmenorrhea: endometriosis. Dysmenorrhea, M. Y. Da-wood. Williams and Wilkins, Baltimore 1981; 131
   Google Scholar
• Cohen M. R. The relation of endometriosis and infertility. Endometriosis, Proceedings of a Symposium, J. J. Frank. Excerpta Medica, Amsterdam 1977; 3
   Google Scholar
• Spangler D. B., Jones G. S., Jones H. W. Infertility due to endometriosis: conservative surgical therapy. Am. J. Obstet. Gynecol. 1971; 109: 850
   Google Scholar
• Ylikorkala O., Viinikka L. Prostaglandins and endometriosis. Acta Obstet. Gynecol. Scand. Suppl. 1983; 113: 105
   Google Scholar
• Schenken R. S., Asch R. H., Williams R. F., Hodgen G. D. Etiology of infertility in monkeys with endometriosis: measurement of peritoneal fluid prostaglandins. Am. J. Obstet. Gynecol. 1984; 150: 349
   Google Scholar
• Moon Y. S., Leung P. C. S., Yuen B. H., Gomel V. Prostaglandin F in human endometriotic tissue. Am. J. Obstet. Gynecol. 1981; 141: 344
   Google Scholar
• Ylikorkala O. Prostaglandin and endometriosis. The First Congress of the International Society of Gynecological Endocrinology. 1988; 45, Crans Montana, March 6-12. Abstracts
   Google Scholar
• Konincks P. R., Renaer M., Brosens I. A. Origin of peritoneal fluid in women: an ovarian exudation product. Br. J. Obstet. Gynaecol. 1980; 87: 177
   Google Scholar
• Rock J. A., Dubin N. H., Ghodgaonkar R. B., Bergqvist C. A., Erozan Y. S., Kimball A. W. Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle – days 8 to 12. Fertil. Steril 1982; 37: 747
   PubMed Web of Science ®Google Scholar
• Dawood M. Y., Khan-Dawood F. S., Wilson L. Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. Am. J. Obstet. Gyencol. 1984; 148: 391
   PubMedGoogle Scholar
• Sgarlata C. S., Hertelendy F., Mikhail G. The prostanoid content in peritoneal fluid and plasma of women with endometriosis. Am. J. Obstet. Gynecol 1983; 147: 563
   PubMedGoogle Scholar
• Mudge T. J., James M. J., Jones W. R., Walsh J. A. Peritoneal fluid 6-keto-prostaglandin Fi., levels in women with endometriosis. Am.]. Obstet. Gynecol 1985; 152: 901
   Google Scholar
• De Leon F. D., Vijayakumar R., Brown M., Rao V., Yussman M. A., Schultz G. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis. Obstet. Gynecol 1986; 68: 189
   PubMed Web of Science ®Google Scholar
• Drake T. S., Metz S. A., Grunert G. M., O'Brien W. F. Peritoneal fluid volume in endometriosis. Fertil. Steril 1980; 34: 280
   PubMed Web of Science ®Google Scholar
• Halme J., Becker S., Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am. J. Obstet. Gynecol 1984; 148: 85
   PubMed Web of Science ®Google Scholar
• Drake T. S., O'Brien W. F., Ramwell P. W., Metz S. A. Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1α., in endometriosis. Am. J. Obstet. Gynecol 1981; 140: 401
   PubMed Web of Science ®Google Scholar
• Badawy S. Z. A., Cuenca V., Marshall L., Munchback R., Rinas A. C., Coble D. A. Cellular components in peritoneal fluid in infertile patients with and without endometriosis. Fertil. Steril 1984; 42: 704
   PubMedGoogle Scholar
• Sgarlata C. S., Hertelendy F., Mikhail G. The prostanoid content in peritoneal fluid and plasma of women with endometriosis. Am. J. Obstet. Gynecol 1983; 147: 563
   PubMedGoogle Scholar
• Ylikorkala O., Koshinimies A., Laatkainen T., Tenhunen A., Viinikka L. Peritoneal fluid prostaglandins in endometriosis, tubal disorders, and unexplained infertility. Obstet. Gynecol 1984; 63: 616
   Google Scholar
• Schade U. F., Moll H., Rietschel E. Th. Metabolism of exogenous arachidonic acid by mouse peritoneal macrophages. Prostaglandins 1987; 34: 401
   Google Scholar
• Halme J., Becker S., Hammond M. G., Ray M. H. G., Ray S. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am. J. Obstet. Gynecol 1983; 145: 333
   PubMed Web of Science ®Google Scholar
• Weed J. C. Prostaglandins as related to endometriosis. Clin. Obstet. Gynecol 1980; 23: 895
   Google Scholar
• Kauppila A., Rönnberg L., Ylikorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 1979; 18: 655
   PubMedGoogle Scholar
• Covens A. L., Christofer P., Casper R. F. The effect of dietary supplementation with fish oil fatty acids on surgically induced endometriosis in the rabbit. Fertil. Steril 1988; 49: 698
   PubMed Web of Science ®Google Scholar
• Nigam S., Rosendhal U., Benedetto C., Slater T. F. Platelet activating factor (PAF): its significance in the endometriosis-associated infertility. The 6th International Conference on Prostaglandins and Related Substances, Florence, 1986; 310, June 3-6. Abstracts
   Google Scholar
• Greene R. Menstrual headache. Research and Clinical Studies in Headache, A. P. Friedman. Karger, Basle 1967; 1: 62
   Google Scholar
• Nattero G. Menstrual headache. Advances in Neurology, M. Critchley, A. P. Friedman, S. Gorini, F. Sicuteri. Raven Press, New York 1982; 33: 215
   Google Scholar
• Edelson R. N. Menstrual migraine and other hormonal aspects of migraine. Headache 1985; 25: 376
   PubMed Web of Science ®Google Scholar
• Massobrio M., Benedetto C., Zonca M., Melzi E., Nattero G., Allais G., Ancona M., Torre E. Platelet function and prostaglandins in menstrual migraine. The Brain and Female Reproductive Function, A. R. Genazzani, U. Montemagno, C. Nappi, F. Petraglia. Parthenon Publishing, Carnforth 1988; 475
   Google Scholar
• Bergström S., Carlson L. A., Ekelund L.-G., Orö L. Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Acta Physiol. Scand. 1965; 64: 332
   PubMedGoogle Scholar
• Carlson L. A., Ekelund L.-G., Orö L. Clinical and metabolic effects of prostaglandin E1 in man. Acta Med. Scand. 1968; 183: 423
   PubMedGoogle Scholar
• Horrobin D. F. Hypothesis: prostaglandins and migraine. Headache 1977; 17: 113
   PubMed Web of Science ®Google Scholar
• Diamond S. Menstrual migraine and non-steroidal anti-inflammatory agents. Headache 1984; 24: 52
   PubMed Web of Science ®Google Scholar
• Fanchamps A. Einteilung. Pathogenese und medikamentose Behandlung der Migraine und verwandter Kopfschmerzen. Med. Welt 1975; 26: 1518
   Google Scholar
• Parantainen J., Vapaatalo H., Hokkanen E. Clinical aspects of prostaglandins and leukotrienes in migraine. Cephalalgia 1986; 61(Suppl. 4)95
   Google Scholar
• Ferreira S. H. Site of analgesic action of aspirin-like drugs and opioids. Mechanism of Pain and Analgesic Compounds, E. G. Bassett, R. E. Beers. Raven Press, New York 1979; 309
   Google Scholar
• Piper P. J., Stanton A. W. B. Leukotrienes and the intracranial circulation. Advances in Prostaglandins, Thromboxane and Leukotrienes Research, O. Hayaishi, S. Yamamoto. Raven Press, New York 1985; 15: 333
   Google Scholar
• Levine J. D., Lau W., Kwiat G., Goetzel E. J. LeukotrieneB4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 1984; 225: 743
   PubMedGoogle Scholar
• Bray M. A., Cunningham F. M., Ford-Hutchinson A. W., Smith M. J. H. Leukotriene B4: a mediator of vascular permeability. Br. J. Pharmacol 1981; 72: 483
   PubMedGoogle Scholar
• Gimbrone M. A., Brock A. F., Schafer A. I. Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J. Clin. Invest. 1984; 74: 1552
   PubMed Web of Science ®Google Scholar
• Gazzaniga P. P., Ferroni P., Lenti L., Lombardi D., Mina C., Pulcinelli F. M., Rizzo P. A., Pontieri G. M. Identification of blood leukotrienes in classical migraine. Headache 1987; 27: 211
   Google Scholar
• Selmaj K., De Belleroche J., Das I., Clifford Rose F. Leuko-triene B4 generation by polymorphonuclear leukocytes: possible involvement in the pathogenesis of headache. Headache 1986; 26: 460
   PubMedGoogle Scholar
• Rae S. A., Davidson E. M., Smith M. J. H. Leukotriene B4, an inflammatory mediator in gout. Lancet 1982; ii: 1122
   Google Scholar
• Setty B. N., Ganley C., Stuart M. J. Effects of changes in oxygen tension on vascular and platelet hydroxyacid metabolites. II. Hypoxia increases 15-hydroxyeicosatetraenoic acid, a proangiogenic metabolite. Pediatrics 1985; 75: 911
   Google Scholar
• Sedgwick J. B., Berube H. L., Zurier R. B. Stimulus-dependent inhibition of superoxide generation by prostaglandins. Clin. Immunol. Immunopathol. 1985; 34: 205
   Google Scholar
• Lewis P. J., Boylan P., Friedman L. A., Hensby C. N., Downing I. Prostacyclin in pregnancy. Br. Med. J. 1980; 1: 1581
   Google Scholar
• Lance J. W. Mechanism and Management of Headache, J. W. Lance. Butterworths Scientific, London 1982; 142
   Google Scholar
• Winther K., Hedman C. Beta-adrenoceptor blockade, platelets, and rheologic factors. Cephalalgia 1986; 6(Suppl. 5)33
   Google Scholar
• Peatfield R. C., Gawel M. J., Clifford Rose F. The effect of infused prostacyclin in migraine and cluster headache. Headache 1981; 21: 190
   Google Scholar
• Tyler H. M. Dazoxiben: a pharmacological tool or clinical candidate?. Br. J. Clin. Pharmacol. 1983; 15: 13
   Google Scholar
• Rackham A., Ford-Hutchinson A. W. Inflammation and pain sensitivity: effects of leukotrienes D4, B4 and prostaglandin E in the rat paw. Prostaglandins 1983; 25: 193
   PubMedGoogle Scholar
• Busija D. W., Leffler C. W. Leukotrienes increase levels of prostanoids in cerebrospinal fluid in piglets. Prostaglandins 1986; 32: 803
   Google Scholar
• Ferreira S. H. Prostaglandins: peripheral and central analgesia. Adv. Pain Res. Ther. 1983; 5: 627
   Google Scholar